Midazolam Patent Expiration
Midazolam was first introduced by Ucb Inc
Midazolam Patents
Given below is the list of patents protecting Midazolam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Midazolam In 0.9% Sodium Chloride | US10966990 | Midazolam in flexible bags | Jun 20, 2038 | Inforlife |
| Nayzilam | US8217033 | Methods and compositions for the delivery of a therapeutic agent | Jan 18, 2028 | Ucb Inc |
| Nayzilam | US8809322 | Methods and compositions for the delivery of a therapeutic agent | Jan 18, 2028 | Ucb Inc |
| Nayzilam | US9289432 | Methods and compositions for the delivery of a therapeutic agent | Jan 18, 2028 | Ucb Inc |
| Nayzilam | US9687495 | Methods and systems for the delivery of a therapeutic agent | Jan 18, 2028 | Ucb Inc |
Explore Our Curated Drug Screens
Midazolam Generics
Several generic applications have been filed for Midazolam.
Given below is the list of companies who have filed for Midazolam generic.
1. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Midazolam. All of these versions come by the name MIDAZOLAM IN 0.9% SODIUM CHLORIDE. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/50ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | Apr 17, 2023 |
| 100MG/100ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | Apr 17, 2023 |